You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)

Article metrics

Article menu

Download PDFPDF

Valvular heart disease
Original research article
Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20176021330
Jul 20171091086
Aug 201712212236
Sep 2017848413
Oct 201754549
Nov 201744447
Dec 201735354
Jan 2018464510
Feb 201833292
Mar 201844422
Apr 201828275
May 201837379
Jun 201836360
Jul 201830301
Aug 201834337
Sep 201811112
Oct 201814142
Nov 201816163
Dec 201812114
Jan 201913132
Feb 201911114
Mar 201917177
Apr 2019445
May 2019554
Jun 2019101011
Jul 2019884
Aug 2019964
Sep 20191263
Oct 20191271
Nov 201918144
Dec 201923137
Jan 20201592
Feb 202025223
Mar 20201083
Apr 2020773
May 2020894
Jun 202012126
Jul 2020161621
Aug 2020556
Sep 202017176
Oct 202010105
Nov 2020976
Dec 2020976
Jan 202114146
Feb 2021445
Mar 202111123
Apr 2021875
May 2021333
Jun 202111112
Jul 2021543
Aug 2021556
Sep 2021665
Oct 2021151520
Nov 20218814
Dec 202118196
Jan 202216151
Feb 202212139
Mar 2022997
Apr 2022872
May 2022668
Jun 2022773
Jul 2022874
Aug 202217165
Sep 2022978
Oct 202214146
Nov 2022689
Dec 2022559
Jan 2023883
Feb 202326262
Mar 2023891
Apr 20236513
May 2023665
Jun 2023774
Jul 2023111110
Aug 2023664
Sep 202312113
Oct 2023552
Nov 2023771
Dec 202317173
Jan 2024774
Feb 2024336
Mar 202411118
Total14991595497